News
Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer therapies through AI-powered drug discovery, is pleased to highlight its ...
Fundamental Global Inc. (Nasdaq: FGF, FGFPP) (the “Company” or “Fundamental Global”) today announced the pricing and signing of a private placement for the purchase and sale of 40,000,000 prefunded ...
The luxury house posted sales of 3.9 billion euros in the second quarter, citing brand equity, scarcity and steady demand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results